VIATRIS INC

Health Issues

Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Part D Formulary Design and Generic Drug Tiering Electronic Labeling of Prescription Drugs FDA facility inspections Medicare incentives for biosimilar utilization Generic Drug User Fee Amendments (GDUFA) Complex Generic Drug Approvals H.R. 3 - Lower Drug Costs Now Act H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act Biosimilar interchangeability H.R. 5376 - Build Back Better Act

TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Management & Budget (OMB) · Commerce, Dept of (DOC) · Health & Human Services, Dept of (HHS) · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)

Trade (domestic/foreign)

Trade issues related to generic medicines Pharmaceutical supply chain

TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Management & Budget (OMB) · Commerce, Dept of (DOC) · Health & Human Services, Dept of (HHS) · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code